ImmunityBio, Inc 10-Q for FY2021 Q2
ImmunityBio, Inc. (IBRX)
10-Q
2021-08-12
For: 2021-06-30
View Original
Added on
April 10, 2026
About this 10-Q
ImmunityBio, Inc filed this 10-Q on August 12, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).
Headline figures
Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $339K
- down 22.2% from $436K a year earlier
- Net loss
- $88.29M
- compared with a net loss of $51.44M a year earlier